Sang Mo Kang, MD

Education

Cornell University, Ithaca, NY, B.A., 1986, Chemistry
Harvard Medical School, Boston, MA, MD, 1992, Magna Cum Laude
General Surgery Program, University of California at San Francisco, June 1992 to June 1999
University of California, San Francisco, CA, 7/99-3/01, Fellow in Transplant Surgery

Honors & Awards

• 1986
  Phi Beta Kappa
• 1986
  Merck Scholarship
• 1985-87
  Beinecke Memorial National Scholar
• 1987
  NIH Outstanding Summer Research Fellow Award
• 1989
  Francis D. Moore Scholarship
• 1991-92
  Howard Hughes Medical Institute Continuing Fellowship for "exceptional promise in biomedical research"
• 1992
  Henry Asbury Christian Award for outstanding academic achievement
• 1995
  British Journal of Surgery Award for outstanding surgical resident
• 1995-97
  Howard Hughes Medical Institute Postdoctoral Fellowship Award
• 1997
  ASTS Upjohn Award for most outstanding paper
• 1997-98
  Hefne Research Grant
• 1998
  Elected to AOA for excellence in teaching
• 1999
  ASTS Travel Award
• 1999-2001
  ASTS Novartis Fellowship in Transplantation
• 2003-2005
  ASTS Faculty Development Award

Selected Publications

1. Lee AY, Lehrman ED, Perito ER, Kerlan RK, Kohi MP, Kolli KP, Taylor AG, Ostroff JW, Kang SM, Roberts JP, Rhee S, Rosenthal P, Fidelman N. Non-operative management of biliary complications after Liver Transplantation in pediatric patients: A 30-year experience. Pediatr Transplant. 2021 Sep; 25(6):e14028.  View on PubMed
2. Braun HJ, Torres AM, Louie F, Weinberg SD, Kang SM, Ascher NL, Roberts JP. Expanding living donor liver transplantation: Report of first US living donor liver transplant chain. Am J Transplant. 2021 04; 21(4):1633-1636.  View on PubMed
3. Syed SM, Gardner J, Roll G, Webber A, Mehta N, Shoji J, Adelmann D, Niemann C, Braun HJ, Mello A, Yao F, Posselt A, Kang SM, Hirose R, Roberts J, Feng S, Ascher N, Stock P, Freise C. COVID-19 and Abdominal Transplant: A Stepwise Approach to Practice During Pandemic Conditions. Transplantation. 2020 11; 104(11):2215-2220.  View on PubMed
4. Yamanaga S, Freise CE, Stock PG, Rosario A, Fernandez D, Kobayashi T, Tavakol M, Kang SM. Inferior Long-Term Graft Survival of Suboptimal Kidneys After Living Donor Kidney Transplantation. Transplant Proc. 2020 Jul - Aug; 52(6):1734-1740.  View on PubMed
5. Gupta N, Henry RG, Kang SM, Strober J, Lim DA, Ryan T, Perry R, Farrell J, Ulman M, Rajalingam R, Gage A, Huhn SL, Barkovich AJ, Rowitch DH. Long-Term Safety, Immunologic Response, and Imaging Outcomes following Neural Stem Cell Transplantation for Pelizaeus-Merzbacher Disease. Stem Cell Reports. 2019 08 13; 13(2):254-261.  View on PubMed
6. Yamanaga S, Rosario A, Fernandez D, Kobayashi T, Tavakol M, Stock PG, Kang SM. Inferior long-term graft survival after end-to-side reconstruction for two renal arteries in living donor renal transplantation. PLoS One. 2018; 13(7):e0199629.  View on PubMed
7. Yamanaga S, Posselt AM, Freise CE, Kobayashi T, Tavakol M, Kang SM. A Single Perioperative Injection of Dexamethasone Decreases Nausea, Vomiting, and Pain after Laparoscopic Donor Nephrectomy. J Transplant. 2017; 2017:3518103.  View on PubMed
8. Tang Q, Kang SM. Interpretation of transplant biopsies and immune responses following Treg cell therapy. Curr Opin Organ Transplant. 2014 Dec; 19(6):616-20.  View on PubMed
9. Gupta N, Henry RG, Strober J, Kang SM, Lim DA, Bucci M, Caverzasi E, Gaetano L, Mandelli ML, Ryan T, Perry R, Farrell J, Jeremy RJ, Ulman M, Huhn SL, Barkovich AJ, Rowitch DH. Neural stem cell engraftment and myelination in the human brain. Sci Transl Med. 2012 Oct 10; 4(155):155ra137.  View on PubMed
10. Tang Q, Leung J, Melli K, Lay K, Chuu EL, Liu W, Bluestone JA, Kang SM, Peddi VR, Vincenti F. Altered balance between effector T cells and FOXP3+ HELIOS+ regulatory T cells after thymoglobulin induction in kidney transplant recipients. Transpl Int. 2012 Dec; 25(12):1257-67.  View on PubMed
11. Tang Q, Bluestone JA, Kang SM. CD4(+)Foxp3(+) regulatory T cell therapy in transplantation. J Mol Cell Biol. 2012 Feb; 4(1):11-21.  View on PubMed
12. Lopez-Vergès S, Milush JM, Schwartz BS, Pando MJ, Jarjoura J, York VA, Houchins JP, Miller S, Kang SM, Norris PJ, Nixon DF, Lanier LL. Expansion of a unique CD57?NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc Natl Acad Sci U S A. 2011 Sep 06; 108(36):14725-32.  View on PubMed
13. Ahearn AJ, Posselt AM, Kang SM, Roberts JP, Freise CE. Experience with laparoscopic donor nephrectomy among more than 1000 cases: low complication rates, despite more challenging cases. Arch Surg. 2011 Jul; 146(7):859-64.  View on PubMed
14. Alemi F, Kwon E, Freise C, Kang SM, Hirose R, Stewart L, Corvera CU. Hepatic surgery at a VA tertiary medical center: lessons learned. Am J Surg. 2010 Nov; 200(5):591-5.  View on PubMed
15. Brennan TV, Hoang V, Garrod KR, Liu FC, Hayden T, Kim J, Kang SM. A new T-cell receptor transgenic model of the CD4+ direct pathway: level of priming determines acute versus chronic rejection. Transplantation. 2008 Jan 27; 85(2):247-55.  View on PubMed
16. Kim J, Chang CK, Hayden T, Liu FC, Benjamin J, Hamerman JA, Lanier LL, Kang SM. The activating immunoreceptor NKG2D and its ligands are involved in allograft transplant rejection. J Immunol. 2007 Nov 15; 179(10):6416-20.  View on PubMed
17. Kang SM. Investigating the immunological mechanisms underlying organ transplant rejection. J Vis Exp. 2007; (7):256.  View on PubMed
18. Liu F, Kang SM. Small bowel transplantation in mice. J Vis Exp. 2007; (7):258.  View on PubMed
19. Liu F, Kang SM. Heterotopic heart transplantation in mice. J Vis Exp. 2007; (6):238.  View on PubMed
20. Garrod KR, Chang CK, Liu FC, Brennan TV, Foster RD, Kang SM. Targeted lymphoid homing of dendritic cells is required for prolongation of allograft survival. J Immunol. 2006 Jul 15; 177(2):863-8.  View on PubMed

Go to UCSF Profiles, powered by CTSI